Deborah R Kaye
Assistant Professor of Surgery
Current Appointments & Affiliations
- Assistant Professor of Surgery, Surgery, Urology, Surgery 2021
- Core Faculty Member, Duke-Margolis Center for Health Policy, Duke - Margolis Center For Health Policy, Initiatives 2019
- Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2019
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2019
Contact Information
- 20 Medicine Circle, Durham, NC 27710
-
deborah.kaye@duke.edu
(919) 684-2410
- Background
-
Education, Training, & Certifications
- Fellow, Society of Urologic Oncology, Urology, University of Michigan, Ann Arbor 2016 - 2019
- M.S., University of Michigan, Ann Arbor 2017
- Urology Resident, Johns Hopkins Medicine 2011 - 2016
- General Surgery Intern, Surgery, Johns Hopkins Medicine 2010 - 2011
- M.D., Medical College of Wisconsin 2010
- Fellow, Clinical Research Training Program, National Institutes of Health 2008 - 2009
- B.A., Washington University in St. Louis 2002
-
Previous Appointments & Affiliations
- Assistant Professor of Surgery, Surgery, Urology, Surgery 2019 - 2020
- Research
-
Selected Grants
- Improving outcomes of patients with advanced prostate cancer through a better understanding of provider decision-making awarded by National Institutes of Health 2022 - 2027
- Decreasing the Financial Burden for Patients with Advanced Prostate Cancer By Understanding Provider Decision-Making awarded by American Urological Association Foundation 2021 - 2022
- Disparities in the Use of Oral Anticancer Agents in Kidney Cancer awarded by National Institutes of Health 2019 - 2020
-
External Relationships
- Janssen Pharmaceuticals (Johnson & Johnson)
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Kaye, Deborah R., Hui-Jie Lee, Alexander Gordee, Daniel J. George, Peter A. Ubel, Charles D. Scales, and M Kate Bundorf. “Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer.” Jco Oncol Pract 19, no. 4 (April 2023): e600–617. https://doi.org/10.1200/OP.22.00645.Full Text Link to Item
-
Dzimitrowicz, Hannah E., Lauren E. Wilson, Bradford E. Jackson, Lisa P. Spees, Christopher D. Baggett, Melissa A. Greiner, Deborah R. Kaye, et al. “End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy.” Jco Oncol Pract 19, no. 2 (February 2023): e213–27. https://doi.org/10.1200/OP.22.00401.Full Text Link to Item
-
Dinan, Michaela A., Lauren E. Wilson, Melissa A. Greiner, Lisa P. Spees, Jessica E. Pritchard, Tian Zhang, Deborah Kaye, et al. “Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC).” Urology 168 (October 2022): 129–36. https://doi.org/10.1016/j.urology.2022.07.012.Full Text Link to Item
-
Pritchard, Jessica E., Lauren E. Wilson, Samuel M. Miller, Melissa A. Greiner, Harvey Jay Cohen, Deborah R. Kaye, Tian Zhang, and Michaela A. Dinan. “Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma.” J Am Geriatr Soc 70, no. 8 (August 2022): 2330–43. https://doi.org/10.1111/jgs.17826.Full Text Link to Item
-
Miller, Samuel M., Lauren E. Wilson, Melissa A. Greiner, Jessica E. Pritchard, Tian Zhang, Deborah R. Kaye, Harvey Jay Cohen, Robert D. Becher, Linda L. Maerz, and Michaela A. Dinan. “Evaluation of mild cognitive impairment and dementia in patients with metastatic renal cell carcinoma.” J Geriatr Oncol 13, no. 5 (June 2022): 635–43. https://doi.org/10.1016/j.jgo.2021.12.012.Full Text Link to Item
-
Herrel, Lindsey A., Ziwei Zhu, Jennifer J. Griggs, Deborah R. Kaye, James M. Dupree, Chandy S. Ellimoottil, and David C. Miller. “Association Between Delivery System Structure and Intensity of End-of-Life Cancer Care.” Jco Oncol Pract 16, no. 7 (July 2020): e590–600. https://doi.org/10.1200/JOP.19.00667.Full Text Link to Item
-
Kaye, Deborah R., Amy N. Luckenbaugh, Mary Oerline, Brent K. Hollenbeck, Lindsey A. Herrel, Justin B. Dimick, and John M. Hollingsworth. “Understanding the Costs Associated With Surgical Care Delivery in the Medicare Population.” Ann Surg 271, no. 1 (January 2020): 23–28. https://doi.org/10.1097/SLA.0000000000003165.Full Text Link to Item
-
Ginsburg, Kevin B., Rohith Arcot, Ji Qi, Susan M. Linsell, Deborah R. Kaye, Arvin K. George, Michael L. Cher, and Michael L. MUSIC. “Confirmatory Magnetic Resonance Imaging with or without Biopsy Impacts Decision Making in Newly Diagnosed Favorable Risk Prostate Cancer.” J Urol 201, no. 5 (May 2019): 923–28. https://doi.org/10.1097/JU.0000000000000059.Full Text Link to Item
-
Kaye, Deborah R., Ji Qi, Todd M. Morgan, Susan Linsell, Kevin B. Ginsburg, Brian R. Lane, James E. Montie, Michael L. Cher, David C. Miller, and David C. Michigan Urological Surgery Improvement Collaborative. “Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.” Bju Int 123, no. 5 (May 2019): 846–53. https://doi.org/10.1111/bju.14554.Full Text Link to Item
-
Kaye, Deborah R., Rodney L. Dunn, Jonathan Li, Lindsey A. Herrel, James M. Dupree, David C. Miller, and Chad Ellimoottil. “Variation in Physician-Specific Episode Payments for Major Cancer Surgery and Implications for the Merit-Based Incentive Program.” J Surg Res 236 (April 2019): 30–36. https://doi.org/10.1016/j.jss.2018.09.073.Full Text Link to Item
-
Kaye, Deborah R., Zaojun Ye, Jonathan Li, Lindsey A. Herrel, James M. Dupree, Chad Ellimoottil, and David C. Miller. “The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program.” Urology 123 (January 2019): 114–19. https://doi.org/10.1016/j.urology.2018.04.051.Full Text Link to Item
-
Kaye, Deborah R., Ji Qi, Todd M. Morgan, Susan Linsell, Brian R. Lane, James E. Montie, Michael L. Cher, David C. Miller, and David C. Michigan Urological Surgery Improvement Collaborative. “Association Between Early Confirmatory Testing and the Adoption of Active Surveillance for Men With Favorable-risk Prostate Cancer.” Urology 118 (August 2018): 127–33. https://doi.org/10.1016/j.urology.2018.04.038.Full Text Link to Item
-
Kaye, Deborah R., Hye Sung Min, Lindsey A. Herrel, James M. Dupree, Chad Ellimoottil, and David C. Miller. “Costs of Cancer Care Across the Disease Continuum.” Oncologist 23, no. 7 (July 2018): 798–805. https://doi.org/10.1634/theoncologist.2017-0481.Full Text Link to Item
-
Li, Jonathan, Zaojun Ye, James M. Dupree, Brent K. Hollenbeck, Hye Sung Min, Deborah Kaye, Lindsey A. Herrel, David C. Miller, and Chad Ellimoottil. “Association of Delivery System Integration and Outcomes for Major Cancer Surgery.” Ann Surg Oncol 25, no. 4 (April 2018): 856–63. https://doi.org/10.1245/s10434-017-6312-6.Full Text Link to Item
-
Kaye, Deborah R., Hye Sung Min, Edward C. Norton, Zaojun Ye, Jonathan Li, James M. Dupree, Chad Ellimoottil, David C. Miller, and Lindsey A. Herrel. “System-Level Health-Care Integration and the Costs of Cancer Care Across the Disease Continuum.” J Oncol Pract 14, no. 3 (March 2018): e149–57. https://doi.org/10.1200/JOP.2017.027730.Full Text Link to Item
-
Kaye, Deborah R., John Syrjamaki, Chad Ellimoottil, Edward W. Schervish, M Hugh Solomon, Susan Linsell, James E. Montie, David C. Miller, James M. Dupree, and James M. Michigan Urological Surgery Improvement Collaborative and the Michigan Value Collaborative. “Use of Routine Home Health Care and Deviations From an Uncomplicated Recovery Pathway After Radical Prostatectomy.” Urology 112 (February 2018): 74–79. https://doi.org/10.1016/j.urology.2017.11.004.Full Text Link to Item
-
Ellimoottil, Chad, Jonathan Li, Zaojun Ye, James M. Dupree, Hye Sung Min, Deborah Kaye, Lindsey A. Herrel, and David C. Miller. “Episode-based Payment Variation for Urologic Cancer Surgery.” Urology 111 (January 2018): 78–85. https://doi.org/10.1016/j.urology.2017.08.053.Full Text Link to Item
-
Hu, J. C., J. J. Tosoian, J. Qi, D. Kaye, A. Johnson, S. Linsell, J. E. Montie, et al. “Clinical utility of gene expression classifiers in men with newly diagnosed prostate cancer.” Jco Precision Oncology 2 (January 1, 2018): 1–15. https://doi.org/10.1200/PO.18.00163.Full Text
-
Kaye, Deborah R., Caroline R. Richardson, Zaojun Ye, Lindsey A. Herrel, Chad Ellimoottil, and David C. Miller. “Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer Surgery.” Ann Surg Oncol 24, no. 12 (November 2017): 3486–93. https://doi.org/10.1245/s10434-017-6049-2.Full Text Link to Item
-
Kaye, Deborah R., Edward C. Norton, Chad Ellimoottil, Zaojun Ye, James M. Dupree, Lindsey A. Herrel, and David C. Miller. “Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgery.” Cancer 123, no. 21 (November 1, 2017): 4259–67. https://doi.org/10.1002/cncr.30866.Full Text Link to Item
-
Kaye, Deborah R., David C. Miller, and Chad Ellimoottil. “Alternative payment models and urology.” Curr Opin Urol 27, no. 4 (July 2017): 360–65. https://doi.org/10.1097/MOU.0000000000000403.Full Text Link to Item
-
Chappidi, Meera R., Max Kates, Hiten D. Patel, Jeffrey J. Tosoian, Deborah R. Kaye, Nikolai A. Sopko, Danny Lascano, Jen-Jane Liu, James McKiernan, and Trinity J. Bivalacqua. “Frailty as a marker of adverse outcomes in patients with bladder cancer undergoing radical cystectomy.” Urol Oncol 34, no. 6 (June 2016): 256.e1-256.e6. https://doi.org/10.1016/j.urolonc.2015.12.010.Full Text Link to Item
-
Kaye, D. R., J. K. Canner, M. Kates, M. P. Schoenberg, and T. J. Bivalacqua. “Do African American patients treated with radical cystectomy for bladder cancer have worse overall survival? Accounting for pathologic staging and patient demographics beyond race makes a difference.” Bladder Cancer 2, no. 2 (January 1, 2016): 225–34. https://doi.org/10.3233/BLC-150041.Full Text
-
Kaye, Deborah R., Jeffrey K. Mullins, H Ballentine Carter, and Trinity J. Bivalacqua. “Robotic surgery in urological oncology: patient care or market share?” Nat Rev Urol 12, no. 1 (January 2015): 55–60. https://doi.org/10.1038/nrurol.2014.339.Full Text Link to Item
-
Kaye, Deborah R., Dan Stoianovici, and Misop Han. “Robotic ultrasound and needle guidance for prostate cancer management: review of the contemporary literature.” Curr Opin Urol 24, no. 1 (January 2014): 75–80. https://doi.org/10.1097/MOU.0000000000000011.Full Text Link to Item
-
Kaye, Deborah R., M Eric Hyndman, Robert L. Segal, Lynda Z. Mettee, Bruce J. Trock, Zhaoyong Feng, Li-Ming Su, Trinity J. Bivalacqua, and Christian P. Pavlovich. “Urinary outcomes are significantly affected by nerve sparing quality during radical prostatectomy.” Urology 82, no. 6 (December 2013): 1348–53. https://doi.org/10.1016/j.urology.2013.06.067.Full Text Link to Item
-
Berenson, Robert A., and Deborah R. Kaye. “Grading a physician's value--the misapplication of performance measurement.” N Engl J Med 369, no. 22 (November 28, 2013): 2079–81. https://doi.org/10.1056/NEJMp1312287.Full Text Link to Item
-
Hyndman, M. E., D. Kaye, N. C. Field, K. A. Lawson, N. D. Smith, G. D. Steinberg, M. P. Schoenberg, and T. J. Bivalacqua. “The use of regenerative medicine in the management of invasive bladder cancer.” Advances in Urology, September 19, 2012. https://doi.org/10.1155/2012/653652.Full Text
-
Kaye, Deborah R., Patrick C. Walsh, George J. Netto, Nilda Gonzalez-Roibon, and Ronald Rodriguez. “A 66-year-old man with prostate-specific antigen recurrence and lung mass after radical prostatectomy.” Urology 80, no. 2 (August 2012): 247–49. https://doi.org/10.1016/j.urology.2012.03.010.Full Text Link to Item
-
Kaye, Deborah R., Benjamin B. Storey, Karel Pacak, Peter A. Pinto, W Marston Linehan, and Gennady Bratslavsky. “Partial adrenalectomy: underused first line therapy for small adrenal tumors.” J Urol 184, no. 1 (July 2010): 18–25. https://doi.org/10.1016/j.juro.2010.03.052.Full Text Link to Item
-
Bisno, A. L., W. E. Dismukes, D. T. Durack, E. L. Kaplan, A. W. Karchmer, D. Kaye, M. A. Sande, J. P. Sanford, and W. R. Wilson. “Treatment of infective endocarditis due to viridans streptococci, This statement was prepared by the ad hoc subcommittee on Treatment of Bacterial endocarditis of the American Heart Association Council on Cardiovascular Disease in the Young.” Circulation 63, no. 3 (March 1981): 730A-733A.Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.